Sandoz, the generic division of Novartis, announced the opening this month of the Sandoz Packaging Center in Stryków, a project valued at $48 million.
It is one of the largest investment projects in the Polish pharmaceutical sector completed in recent years, according to a press release from Sandoz.
“This investment will greatly facilitate the manufacturing and packaging process, as we will be able to pack around 4 billion of manufactured tablets, without the need to send them to external packaging facilities,” said Ard van der Meij, president of the board of Sandoz Poland. “The plant is expected to reach full production by the end of 2015.
The drug manufacturing plant in Stryków is one of the biggest Sandoz production facilities. The 5 billion tablets manufactured every year in Stryków are exported to nearly 60 countries worldwide. Among others, the Stryków plant produces painkillers, anti-inflammatory medicines (ketoprofen), diabetes medicines (metformin, glimepiride), as well as medications for vascular hypertension (ramipril, torasemide). As part of the enlargement of the Sandoz production and logistics site in Stryków, a modern packaging and warehousing center has been added to the existing manufacturing plant, according to the company.
The construction of the center took nearly two years, starting in June 2013 and ending in the second quarter of 2015. Previously, the majority of the tablets produced in Stryków were transported to other Sandoz facilities. At the first stages of the construction project, eight packaging lines and a fully automated warehousing system were installed in the new building. This will allows the packaging process to be carried out directly at the manufacturing site, the company says.
For more company information, visit http://www.sandoz.com
